Mustafa Yıldırım

37PUBLICATIONS

131CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNutrigenomics and personalised nutrition

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (37)

Sort by Publication Date:

|Jun 26, 2026

Early PSA Decline Predicts Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Retrospective Single-Center Study.

|Jun 26, 2026

Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma.

|Jun 25, 2026

Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss.

|May 27, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 27, 2026

Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Apr 01, 2026

Clinical impact of TP53 mutation status on survival outcomes in metastatic colorectal cancer.

Oğuzhan Yıldız, Hakan Şat Bozcuk, Melek Karakurt Eryılmaz

Pageof 7

Frequent Collaborators

22 joint publications

Melek Karakurt Eryılmaz

20 joint publications

Murat Araz

12 joint publications

Mehmet Zahid Koçak

10 joint publications

Mustafa Karaağaç

10 joint publications

Mustafa Korkmaz

Oğuzhan Yıldız

Engin Hendem

Talat Aykut

Ali Fuat Gürbüz

Muzaffer Uğraklı

Frequent Collaborators

22 joint publications

Melek Karakurt Eryılmaz

20 joint publications

Murat Araz

12 joint publications

Mehmet Zahid Koçak

10 joint publications

Mustafa Karaağaç